Akèy › Sindrom Sjogren › North Carolina › Charlotte
Etid klinik pou Sindrom Sjogren nan Charlotte, NC
4 etid pou Sindrom Sjogren ap chèche patisipan nan sit nan ak bò kote Charlotte (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Ap rekriteFaz 3
- On Site Clinical Solutions Llc, Charlotte
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Ap rekriteFaz 3
- Arthritis and Osteoporosis Consultants of the Carolinas, Charlotte
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Ap rekriteFaz 2
- Artiva Investigational Site Charlotte, Charlotte
- Artiva Investigational Site Charlotte, Charlotte
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Ap rekriteFaz 3
- Arthritis and Osteoporosis Consultants of The Carolinas - Charlotte - 1918 Randolph Rd, Charlotte
Etid Sindrom Sjogren nan lòt vil
- Houston, TX6 etid
- Boston, MA5 etid
- Washington, DC5 etid
- Cicero, IL4 etid
- Tampa, FL4 etid
- Arlington, TX4 etid
- Orlando, FL3 etid
- Kansas City, MO3 etid
- Dallas, TX3 etid
- Clearwater, FL3 etid
- Warren, MI3 etid
- Tucson, AZ3 etid
Lòt etid nan Charlotte
- Kansè (tout kalite)27 etid
- Kansè nan tete22 etid
- Myelom Miltip21 etid
- Kansè Poumon ki pa ti selil19 etid
- Leksemi mieloïd egi16 etid
- Obèsite15 etid
- Sipwa14 etid
- Kansè ovè13 etid
- Kansè kolorektal13 etid
- Ensifizyans kadyak11 etid
- Kansè Metastatik11 etid
- Karsinòm selil skuamèz tèt ak kou10 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 7, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.